The impact of central review and central therapy planning on the treatment of children and adolescents with Hodgkin lymphoma

European Journal of Cancer

Volumn 50, Issue 2, 2014, Pages 425-433

  Lüders, Heike ^a   Rühl, Ursula ^b   Marciniak, Heinz ^c   Haerting, Johannes ^d   Claviez, Alexander ^e   Mann, Georg ^f   Schellong, Günther ^g   Wickmann, Lutz ^h   Dörffel, Wolfgang ^h  

^a Evangelische Lungenklinik Berlin ^*  (Germany)

^b VIVANTES KLINIKUM IM FRIEDRICHSHAIN   (Germany)

^c HELIOS KLINIKUM BERLIN BUCH   (Germany)

^d Institut für Medizinische Epidemiologie Biometrie und Informatik   (Germany)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^f UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

^g UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^h Deutsche Akademie fur Kinder und Jugendmedizin e V   (Germany)

Author keywords

Central review; Hodgkin lymphoma; Paediatric; Reference centre

Indexed keywords

DOXORUBICIN; ETOPOSIDE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; HODGKIN DISEASE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PEDIATRICS; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; TREATMENT PLANNING; TREATMENT RESPONSE;

EID: 84891832028     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.09.017     Document Type: Article

References (14)

1. G. Schellong The balance between cure and late effects in childhood Hodgkin's lymphoma: the experience of the German-Austrian Study-Group since 1978. German-Austrian Pediatric Hodgkin's Disease Study Group Ann Oncol 7 Suppl. 4 1996 67 72
2. W. Dörffel, H. Lüders, and U. Rühl et al. Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlook Klin Pädiatr 215 2003 139 145
3. W. Dörffel, U. Rühl, and H. Lüders et al. Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission following chemotherapy. Final results of the multinational trial GPOH-HD95 J Clin Oncol 31 2013 1562 1568
4. G. Schellong, R. Pötter, and J. Brämswig et al. High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group J Clin Oncol 17 1999 3736 3744
5. E.S. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
6. D.R. Cox Regression models and life-tables J R Stat Soc (series B) 34 1972 187 220
7. K. Dieckmann, R. Potter, and W. Wagner et al. Up-front centralized data review and individualized treatment proposals in a multicenter pediatric Hodgkin's disease trial with 71 participating hospitals: the experience of the German-Austrian pediatric multicenter trial DAL-HD-90 Radiother Oncol 62 2002 191 200
8. H.T. Eich, S. Staar, and A. Gossmann et al. Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field - results of a quality assurance program of the German Hodgkin Study Group Int J Radiat Oncol Biol Phys 58 2004 1121 1127
9. E. Dühmke, J. Franklin, and M. Pfreundschuh et al. Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: long-term results of a randomized trial of radiotherapy alone J Clin Oncol 19 2001 2905 2914
10. B.M. Aleman, T. Girinsky, and R.W. van der Maazen et al. Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884) Int J Radiat Oncol Biol Phys 63 2005 1184 1190
11. B.D. Fletcher, A.S. Glicksman, and P. Gieser Interobserver variability in the detection of cervical-thoracic Hodgkin's disease by computed tomography J Clin Oncol 17 1999 2153 2159
12. K.D. Hopper, C.J. Kasales, M.A. Van Slyke, T.A. Schwartz, T.R. TenHave, and J.A. Jozefiak Analysis of interobserver and intraobserver variability in CT tumor measurements AJR Am J Roentgenol 167 1996 851 854
13. P. Thiesse, L. Ollivier, and D. Di Stefano-Louineau et al. Response rate accuracy in oncology trials: reasons for interobserver variability. Groupe Francais d'Immunotherapie of the Federation Nationale des Centres de Lutte Contre le Cancer J Clin Oncol 15 1997 3507 3514
14. B. Klimm, C. Brillant, and N. Skoetz et al. The effect of specialized cancer treatment centers on treatment efficacy in Hodgkin's lymphoma Dtsch Arztebl Int 109 2012 893 899